Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Novartis
Company Monitoring Page for Novartis
latest headlines for company on cafepharma
Gene therapy startup Vedere to close two years after launch
BioPharma Dive
Sun, 04/2/23 - 04:20 pm
Tags:
Vedere Bio
,
Novartis
,
gene therapy
CHMP gives thumbs-up for Wegovy use in adolescents, along with nine new drug recommendations
Endpoints
Sun, 04/2/23 - 04:17 pm
Tags:
EMA
,
Europe
,
CHMP
,
Wegovy
,
Novo Nordisk
,
Bimervax
,
TG Therapeutics
,
Eli Lilly
,
Bristol Myers Squibb
,
Novartis
,
AstraZeneca
Bicycle, Novartis Ink Oncology Deal Worth up to $1.7B
BioSpace
Tue, 03/28/23 - 11:30 am
Tags:
Bicycle Therapeutics
,
Novartis
,
drug discovery
,
oncology
,
radioligand
Top 10 pharma R&D budgets in 2022
Fierce Biotech
Mon, 03/27/23 - 10:21 pm
Tags:
R&D
,
Roche
,
JNJ
,
Merck
,
Pfizer
,
Novartis
,
AstraZeneca
,
Bristol Myers Squibb
,
Eli Lilly
,
Sanofi
,
AbbVie
Novartis' Kisqali cuts recurrence risk in early-stage breast cancer
BioSpace
Mon, 03/27/23 - 11:27 am
Tags:
Novartis
,
clinical trials
,
Kisqali
,
breast cancer
FDA approves Pharming drug for ultra-rare immunodeficiency disease
Endpoints
Sun, 03/26/23 - 11:16 pm
Tags:
FDA
,
Pharming
,
Novartis
,
leniolisib
,
APDS
Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy
CP Wire
Sun, 03/26/23 - 03:44 pm
Tags:
PTC Therapeutics
,
Novartis
,
Zolgensma
,
SMA
,
Novo Nordisk
,
Ozempic
,
obesity
,
diabetes
,
Baxter
,
M&A
,
Celltrio
,
Thermo Fisher
,
Pfizer
,
Astellas
,
Xtandi
,
NIH
Sun, 03/26/23 - 03:36 pm
Tags:
PTC Therapeutics
,
Novartis
,
Zolgensma
,
SMA
,
Novo Nordisk
,
Ozempic
,
obesity
,
diabetes
,
Baxter
,
M&A
,
Celltrio
,
Thermo Fisher
,
Pfizer
,
Astellas
,
Xtandi
,
NIH
Novartis pulls the plug on UK-based cardiovascular study
Endpoints
Wed, 03/22/23 - 09:11 pm
Tags:
Novartis
,
clinical trials
,
Leqvio
,
UK
,
Cardiovascular
Flare fires up with $123M series B to target transcription factors with 3 Big Pharmas in tow
Fierce Biotech
Wed, 03/22/23 - 10:13 am
Tags:
Flare Therapeutics
,
funding
,
Pfizer
,
Eli Lilly
,
Novartis
,
transcription factors
AACR 2023 – Moderna's immunotherapeutic splash
EP Vantage
Wed, 03/22/23 - 10:03 am
Tags:
AACR
,
Moderna Therapeutics
,
Allogene
,
AstraZeneca
,
Merck
,
Roche
,
Novartis
,
Eli Lilly
,
Innovent
,
Springworks
,
Biogene
,
Relay Therapeutics
,
Vivace Therapeutics
Novartis: SMA Drug Zolgensma Long-term Data Shows Sustained Durability Up To 7.5 Years Post-dosing
NASDAQ
Mon, 03/20/23 - 04:47 pm
Tags:
Novartis
,
SMA
,
Zolgensma
,
gene therapy
Novartis, Biogen Scrap Gene Regulation Partnerships with Sangamo
BioSpace
Mon, 03/20/23 - 09:51 am
Tags:
Sangamo Therapeutics
,
Novartis
,
Biogen
,
neurology
,
gene regulation therapies
Novartis' Tafinlar/Mekinist combo scores new indication in pediatric brain cancer
Endpoints
Sun, 03/19/23 - 01:36 pm
Tags:
Novartis
,
Tafinlar
,
Mekinist
,
pediatric
,
brain cancer
,
FDA
Most-clicked pharma news for week ending March 18 2023: Medtronic offers early retirement package, Novartis to sell ophthalmological assets, and Pfizer tops list of drugs with price increases
CP WIre
Sat, 03/18/23 - 03:37 pm
Tags:
Medtronic
,
Medtech
,
inflation
,
drug pricing
,
Pfizer
,
Novartis
,
Merck
,
Bristol Myers Squibb
,
Keytruda
,
Opdivo
,
Yervoy
,
lung cancer
,
Xiidra
,
JNJ
,
executive compensation
Sat, 03/18/23 - 03:34 pm
Tags:
Medtronic
,
Medtech
,
inflation
,
drug pricing
,
Pfizer
,
Novartis
,
Merck
,
Bristol Myers Squibb
,
Keytruda
,
Opdivo
,
Yervoy
,
lung cancer
,
Xiidra
,
JNJ
,
executive compensation
Novartis and Pfizer-Backed Mediar Nets $85M for Fibrosis Paradigm Shift
BioSpace
Wed, 03/15/23 - 11:17 am
Tags:
Mediar Therapeutics
,
Novartis
,
Pfizer
,
fibrosis
After $3.4B deal and EU withdrawal, Novartis looks to sell Xiidra
Fierce Pharma
Tue, 03/14/23 - 11:30 am
Tags:
Novartis
,
Xiidra
,
ophthalmology
Seeking to boost shareholder returns, Novartis readies new $11B buyback round
Fierce Pharma
Mon, 03/13/23 - 04:42 pm
Tags:
Novartis
,
share repurchase
Sandoz, betting on biosimilar sales, to build new production plant
BioPharma Dive
Thu, 03/9/23 - 09:15 pm
Tags:
Sandoz
,
Novartis
,
drug manufacturing
,
Slovenia
,
biosimilars
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.